193 related articles for article (PubMed ID: 17889375)
1. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
Wang Y; Zhou J; Liu B
Immunol Lett; 2007 Dec; 114(2):73-80. PubMed ID: 17889375
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.
Mannon RB; Nataraj C; Pisetsky DS
Cell Immunol; 2000 Apr; 201(1):14-21. PubMed ID: 10805969
[TBL] [Abstract][Full Text] [Related]
3. CpG motifs for optimization of DNA vaccines.
Davis HL
Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
[TBL] [Abstract][Full Text] [Related]
4. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
Chaung HC
Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
[TBL] [Abstract][Full Text] [Related]
5. Mitogenicity of DNA from different organisms for murine B cells.
Sun S; Beard C; Jaenisch R; Jones P; Sprent J
J Immunol; 1997 Oct; 159(7):3119-25. PubMed ID: 9317108
[TBL] [Abstract][Full Text] [Related]
6. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ
Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in immunostimulatory CpG oligonucleotides.
Rothenfusser S; Tuma E; Wagner M; Endres S; Hartmann G
Curr Opin Mol Ther; 2003 Apr; 5(2):98-106. PubMed ID: 12772497
[TBL] [Abstract][Full Text] [Related]
9. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
10. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
Yamamoto S; Yamamoto T; Nojima Y; Umemori K; Phalen S; McMurray DN; Kuramoto E; Iho S; Takauji R; Sato Y; Yamada T; Ohara N; Matsumoto S; Goto Y; Matsuo K; Tokunaga T
Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant properties of CpG oligonucleotides in primates.
Verthelyi D
Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
[TBL] [Abstract][Full Text] [Related]
12. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
Trevani AS; Chorny A; Salamone G; Vermeulen M; Gamberale R; Schettini J; Raiden S; Geffner J
Eur J Immunol; 2003 Nov; 33(11):3164-74. PubMed ID: 14579285
[TBL] [Abstract][Full Text] [Related]
13. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
[TBL] [Abstract][Full Text] [Related]
14. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
[TBL] [Abstract][Full Text] [Related]
15. CpG motifs in bacterial DNA trigger direct B-cell activation.
Krieg AM; Yi AK; Matson S; Waldschmidt TJ; Bishop GA; Teasdale R; Koretzky GA; Klinman DM
Nature; 1995 Apr; 374(6522):546-9. PubMed ID: 7700380
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
Shoda LK; Kegerreis KA; Suarez CE; Mwangi W; Knowles DP; Brown WC
J Leukoc Biol; 2001 Jul; 70(1):103-12. PubMed ID: 11435492
[TBL] [Abstract][Full Text] [Related]
17. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
[TBL] [Abstract][Full Text] [Related]
18. Activation of toll-like receptor 9 by DNA from different bacterial species.
Dalpke A; Frank J; Peter M; Heeg K
Infect Immun; 2006 Feb; 74(2):940-6. PubMed ID: 16428738
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory DNA as a vaccine adjuvant.
Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
[TBL] [Abstract][Full Text] [Related]
20. The immunophysiological impact of bacterial CpG DNA on the gut.
Watson JL; McKay DM
Clin Chim Acta; 2006 Feb; 364(1-2):1-11. PubMed ID: 16153626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
